Fearless League logo
Software 
Photo51 icon
Photo51Sequence editor for alignment, cloning, and more.
 
Photo51 icon
Photo51Sequence editor for alignment, cloning, and more.
 
Resources 
ArticlesOn molecular biology and lab software tools
GuidesStep-by-step guides for using Photo51
FAQ
ArticlesOn molecular biology and lab software tools
GuidesStep-by-step guides for using Photo51
FAQ
PlansAbout us
  Sign upLog in
  Sign upLog in

Design experiments,
plan cloning,
validate results
and collaborate.

Accelerate your molecular biology research.
Independently or in teams.

Explore: Photo51 features →
  • Inventory with preview
  • CRISPR-Cas tools
  • Split screen
  • Create teams & work together
  • Unlimited installations
Trusted by 1000+ scientists from industry to academia:
Stanford logoLUMC logoHogeschool Leiden logoCespu LogoSynx logoAvans Hogeschool logo
Photo51 Logo

Photo51 is your research platform for:

 

Automated cloning

Constructs built, primers designed, any method done in seconds.

Learn more

 

Sequence alignment

Align to reference, multiple alignment, validate results.

Learn more

 

Shared inventory

Work together in teams, sync files and folders across the cloud.

Learn more

 

gRNA design

Identify PAM sites and plan CRISPR-Cas experiments.

Learn more

 

Genome browser

Explore genomes and download genes, right in the app.

Learn more

 

and more!

PCR, automatic feature detection, agarose gel, etc.

Learn more

Unlimited installations,
desktop and cloud!

Try Photo51 for free →
desktop iconcloud icon

Collaborations

Talent-CGT

Talent-CGT is a European initiative to train the next generation of cell and gene therapy specialists. It builds open digital tools and education modules that bring advanced therapy skills into classrooms and labs.

This project receives funding from the European Institute of Innovation and Technology (EIT), a body of the European Union, under the Horizon Europe program.

EIT raw materials logoFunded by EU logoEIT higher education initiative logo

PRIME-AI

PRIME-AI develops next-generation gene therapies by combining prime editing with artificial intelligence. The project creates smarter design tools, a new editing system, and a robust assay to make advanced therapies safer and more precise.

The collaboration project PRIME-AI is co-funded by PPP Subsidy awarded by Health~Holland, Top Sector Life Sciences & Health, to stimulate public-private partnerships.

Health~Holland logo

IPCEI P-SMaRT

IPCEI P-SMaRT accelerates scalable manufacturing platforms for rare disease gene therapies. The project focuses on Duchenne muscular dystrophy and Diamond-Blackfan anemia to make advanced treatments more accessible.

This project has received funding under the Important Projects of Common European Interest (IPCEI) program.

Funded by EU logo
Fearless League
BioPartner, Room 3036
Galileiweg 8
2333 BD Leiden
The Netherlands
Product
  • Photo51
  • Plans
Resources
  • Resources
  • Guides
  • FAQ
Fearless League
  • About us
  • Privacy policy
  • Cookie Policy
  • Terms of Service
  • EULA

Are you interested in our solutions or want to set up a collaboration?

Get in touch 
Copyright © Fearless League 2026.